Insulin resistance and PCOS: chicken or egg?
The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
PCOS is a common and heterogeneous endocrine disorder in women of reproductive age, frequently associated with metabolic abnormalities. It was estimated that about 75% of these subjects have an impairment of insulin action, as measured by gold standard methods. While the relationship between insulin resistance and PCOS is consistently shown by a number of studies, the mechanisms underlying its primary origin still remains an unsolved issue. Insulin resistance and the associated hyperinsulinemia can induce both the endocrine and reproductive traits of PCOS. However, androgen excess, in turn, can impair insulin action, directly and/or through several changes occurring in different tissues. Body fat excess, which is another common feature in these women, can contribute to worsening the whole picture. Nevertheless, insulin resistance may also be found in many normal-weight individuals. Endocrine and metabolic abnormalities can develop in different moments, and probably there is fetal programming of these alterations. However, a number of vicious circles, with bidirectional relationships between androgen excess and insulin resistance, and with the contribution of several other factors, make it extremely difficult to understand where this process really originates. This review summarizes available evidence on this topic, in order to better understand the complex relationships linking hyperandrogenism and impaired insulin action in women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Consequently, HOMA-IR was selected in this study as the major end point as it plays a significant role in the onset and progression of PCOS.”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [27]
In the citing paper
“Insulin levels, which mainly drive these surrogate indexes, depend on several factors, not only insulin sensitivity and glucose levels. In particular, obesity, age, androgen levels, metabolism and clearance of insulin, and enzymatic degradation of the insulin–receptor complex are perhaps more valuable than insulin itself [44].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [44]
In the citing paper
“The result of all the processes described above is impaired glucose transport into cells by insulin-dependent membrane GLUT 4 transporters, reduced glycogen synthesis and decreased inhibition of hepatic gluconeogenesis. This leads to hyperglycemia and to compensatory hyperinsulinemia.”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [61]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · cited 1×
“Based on the generally adopted Rotterdam diagnostic criteria, established in a workshop consensus of the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embriology (ESHRE) [1], it was estimated that its prevalence is at least 10% [2].”
MethodMoran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Insulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Research works printed but not linked: 1
- Johnson T, Kaplan L, Ouyang P, Rizza P (2012) National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome. NIH EbMW reports. National Institutes of Health, Bethesda 1:1–14. https://www.prevention.nih.gov/sites/default/files/2018-06/FinalReport.pdf. Accessed 31 Mar 2020
Cited by
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
“In particular, obesity, age, androgen levels, metabolism and clearance of insulin, and enzymatic degradation of the insulin–receptor complex are perhaps more valuable than insulin itself [44].”
BackgroundCalcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
“Hyperinsulinemia leads to increased androgen production, which, in turn, may impair insulin sensitivity [98].”
BackgroundTong, C., Wu, Y., Zhang, L., & Yu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1091147 · Cited by 157
“According to statistics, about 75% of PCOS patients develop IR, with a higher percentage of PCOS patients with obesity, and the development of PCOS is also inseparable from IR (3).”
BackgroundBednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148
“IR, the resulting hyperinsulinemia, and increased androgen levels influence each other, and it is difficult to determine which phenomenon occurs first (Figure 4) [61].”
BackgroundSignaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
Wang, K., & Lǐ, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191759 · Cited by 127
“…factors for PCOS: genetic and epigenetic factors, disturbance of the hypothalamus – pituitary – ovary (HPO) axis, environmental toxins, dysbiosis of the gut microbiota, and obesity all contribute to development of the disorder. suppressing lipolysis and promoting lipogenesis of adipocytes (10).”
BackgroundCapece, U., Moffa, S., Improta, I., Giuseppe, G. D., Nista, E. C., CEFALO, C. M. A., Cinti, F., Pontecorvi, A., Gasbarrini, A., Giaccari, A., et al. (2022) · Nutrients · doi:10.3390/nu15010018 · Cited by 109
“It is also well known that these pathological findings often overlap with obesity (32% of PCO patients in USA) [86] and insulin resistance (up to 75% according to some authors) [87].”
BackgroundReappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston, E. J., & Templeman, N. M. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0269 · Cited by 109
Tyrmi, J. S., Arffman, R. K., Pujol‐Gualdo, N., Kurra, V., Morin-Papunen, L. C., Sliz, E., FinnGen, Piltonen, T., Laisk, T., Kettunen, J., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab250 · Cited by 101
“Considering the complex nature of the syndrome, it is likely that both genetic and environmental factors contribute to its development (Abbott et al. , 2019; Koivuaho et al. , 2019; Moghetti and Tosi, 2021).”
Dobbie, L. J., Pittam, B., Zhao, S. S., Alam, U., Hydes, T., Barber, T. M., & Cuthbertson, D. J. (2023) · Human Reproduction · doi:10.1093/humrep/dead053 · Cited by 95
“Insulin resistance induces clinical features of PCOS; however, hyperandrogenaemia (from PCOS) also causes insulin resistance (Moghetti and Tosi, 2021).”
PCOS and nutritional approaches: Differences between lean and obese phenotype
Barrea, L., Frias-Toral, E., Verde, L., Ceriani, F., Cucalón, G., Garcia-Velasquez, E., Moretti, D., Savastano, S., Colao, A., & Muscogiuri, G. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100123 · Cited by 86
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
“Although there is a fair amount of data on the degree and prevalence of IR in women with PCOS, as well as some information on insulin secretion, MCRI was rarely investigated [21].”
BackgroundInfluentialElevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome
Peng, Y., Yang, H., Song, J., Feng, D., Na, Z., Jiang, H., Meng, Y., Shi, B., & Li, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.845165 · Cited by 71
“Risk factors of insulin resistance in PCOS patients include obesity and those related to androgen (25).”
BackgroundZhang, J., Xing, C., Cheng, X., & He, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1003238 · Cited by 73
“In addition to these diagnostic features, obesity and insulin resistance (IR) are common abnormalities associated with PCOS (5).”
BackgroundEffects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism
Chen, H., Deng, C., Meng, Z., & Meng, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.956772 · Cited by 60
“More and more studies have proved that IR regulates multiple mediators and pathways and is seriously involved in the pathogenesis and development of PCOS (65, 66).”
BackgroundPolycystic ovary syndrome (PCOS) and oxidative stress
Sengupta, P., Dutta, S., & Hassan, M. F. (2024) · Journal of Integrated Science and Technology · doi:10.62110/sciencein.jist.2024.v12.752 · Cited by 56
Jiang, X., Tai, H., Xiao, X.-S., Zhang, S., Cui, S.-C., Qi, S.-B., Hu, D., Zhang, L.-N., Kuang, J., Meng, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962154 · Cited by 46
“PCOS is associated with IR in approximately 75% of cases (2).”
BackgroundXu, Q., Zhang, J., Lu, Y., & Wu, L. Y. (2024) · iScience · doi:10.1016/j.isci.2024.108783 · Cited by 50
“17 Thirdly, systematic inflammation is another reason.”
Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review
Mouanness, M., Nava, H. J., Dagher, C., & Merhi, Z. O. (2022) · Nutrients · doi:10.3390/nu14173578 · Cited by 44
“Androgen excess itself can impair proper insulin actions, directly or by multiple changes at various sites in the body, especially in muscle and fat tissue [69].”
BackgroundWang, C., Ding, C., Hua, Z., Chen, C.-Y., & Jia, Y. (2020) · Mediators of Inflammation · doi:10.1155/2020/8865647 · Cited by 42
“But more and more studies evidence that IR regulates multiple mediators and pathways and is critically involved in the pathogenesis and development of PCOS [2, 21].”
BackgroundYang, Y., Zhou, C.-C., Hu, H., Fukuzawa, I., & Zhang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1035929 · Cited by 39
“Insulin resistance and related hyperinsulinemia may induce both the endocrine and reproductive traits of PCOS (108).”
BackgroundAcanthosis Nigricans: Pointer of Endocrine Entities
Radu, A.-M., Carşote, M., Dumitrașcu, M. C., & Şandru, F. (2022) · Diagnostics · doi:10.3390/diagnostics12102519 · Cited by 38
Shen, H., Xu, X. L., Fu, Z., Xu, C., & Wang, Y. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155164 · Cited by 39
Pandurevic, S., Mancini, I., Mitselman, D., Magagnoli, M., Teglia, R., Fazzeri, R., Dionese, P., Cecchetti, C., Caprio, M., Moretti, C., et al. (2023) · Endocrine Connections · doi:10.1530/ec-22-0536 · Cited by 36
Tsai, Y.-R., Liao, Y.-N., & Kang, H. (2023) · Cells · doi:10.3390/cells12172189 · Cited by 39
Yu, Y., Tan, P., Zhuang, Z., Wang, Z., Zhu, L., Qiu, R., & Xu, H. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00962-7 · Cited by 35
Gao, Y., Liu, H., Qiao, L., Liang, J., Yao, H., Lin, X., & Gao, Y. (2023) · Healthcare · doi:10.3390/healthcare11040562 · Cited by 37
Stefanaki, K., Karagiannakis, D. S., Peppa, Μ., Vryonidou, A., Kalantaridou, S., Goulis, D. G., Ψαλτοπούλου, Θ., & Paschou, S. Α. (2024) · Nutrients · doi:10.3390/nu16071049 · Cited by 35
“Subsequently, obesity and hyperan-drogenism trigger anxiety disorders and depression, aggravating further ED [87].”
BackgroundNGF and Its Role in Immunoendocrine Communication during Metabolic Syndrome
Samario-Román, J., Larqué, C., Pánico, P., Ortiz-Huidobro, R. I., Velasco, M., Escalona, R., & Hiriart, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031957 · Cited by 37
A PCOS Paradox: Does Inositol Therapy Find a Rationale in All the Different Phenotypes?
Unfer, V., Dinicola, S., & Russo, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076213 · Cited by 34
“Indeed, as the ovaries remain sensitive to insulin signaling, hyperinsulinemia due to systemic IR may contribute to increased androgen secretion [14] and lead to ovulatory dysfunction [15].”
BackgroundBarrea, L., Verde, L., Annunziata, G., Camajani, E., Caprio, M., Šojat, A. S., Marina, L., Guarnotta, V., Colao, A., & Muscogiuri, G. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02169-2 · Cited by 35
“Insulin resistance represents a metabolic hallmark of PCOS [143, 144].”
BackgroundHyperprolactinemia and insulin resistance
Gierach, M., Bruska-Sikorska, M., Rojek, M., & Junik, R. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0075 · Cited by 36
Zhang, Y., Wang, L., Weng, Y., Wang, D., Wang, R., Wang, H., Wang, L., Shen, S., Wang, H., Li, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2113293 · Cited by 28
“…in fl ammation both contribute to the onset of IR, which might empower androgenic activity, while high levels of androgens may further blunt IR and worsen the clinical presentation of PCOS, which suggests that this vicious circle may play a critical role in the pathophysiology of PCOS [4, 5].”
Zhang, Y., Chen, M., Li, Y., Guo, Y., Yu, Y., Zhi, Z., Hui, L., Si, Y., Wu, C., Zhang, X., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1457467 · Cited by 31
“Within the ovaries, insulin collaborates with LH to stimulate androgen production in the ovarian cells (Moghetti and Tosi, 2021), and exacerbate hyperandrogenism (Janssen, 2022).”
BackgroundKalyanaraman, R., & Pal, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094905 · Cited by 30
Xu, H., Feng, G., Alpadi, K., Han, Y. K., Yang, R. J., Chen, L., Li, R., & Qiao, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.821368 · Cited by 30
Yu, J., Zhou, Y., Ding, J., Zhang, D., Yu, C., & Huang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.970733 · Cited by 31
“Recently, growing evidence has indicated a high prevalence of PCOS in women with IR (7), while research revealed that approximately three-quarters of women with PCOS have impaired insulin sensitivity and about one-third of these women havemetabolic syndrome (8).”
BackgroundPlacental mTOR Signaling and Sexual Dimorphism in Metabolic Health across the Lifespan of Offspring
Beetch, M., & Alejandro, E. U. (2021) · Children · doi:10.3390/children8110970 · Cited by 26
“Obesity and insulin resistance commonly characterize PCOS and can present PCOS mothers with an increased risk for GDM and hypertension [14].”
BackgroundLuo, Z., Wang, L., Wang, Y., Fan, Y., Jiang, L., Xu, X. P., Du, Y., & Hao, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030818 · Cited by 28
“However, IR and hyperinsulinemia may insult follicle development and cause reproductive disorders in PCOS [10].”
BackgroundPolycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review
Hussein, R., Dayel, S. B., & Abahussein, O. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5112269 · Cited by 27
Shi, M., Li, X., Xing, L., Li, Z., Zhou, S., Wang, Z., Zou, X., She, Y., Zhao, R., & Qin, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121556 · Cited by 26
Yang, H., Chen, Y., & Liu, C. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2172154 · Cited by 24
“Insulin resistance has been reported to be one of the potential mechanisms and the central links in the pathogenesis of PCOS and various metabolic diseases [5, 6].”
BackgroundBioinformatics searching of diagnostic markers and immune infiltration in polycystic ovary syndrome
Yao, X., & Wang, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.937309 · Cited by 26
“The insulin resistance have the capacity to induce both the endocrine and reproductive traits of PCOS (Moghetti and Tosi, 2021).”
BackgroundChavez, G. N., Jaworsky, K., & Basu, A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20156534 · Cited by 26
“Insulin can also stimulate androgen secretion in the adrenal cortex to further increase the concentrations of androgens in the bloodstream [10].”
BackgroundWang, R., Zhao, Y., Fang, X., Miao, C., Ren, N., Chen, Y., Cheng, W., & Zhang, Q. (2023) · Nutrition · doi:10.1016/j.nut.2023.112127 · Cited by 22
Fang, Y., Zhang, H., Wei, Q., & Li, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202401346r · Cited by 22
“46 BAT quality is significantly correlated with glucose uptake activity.”
Towards Hormone Health: An Autoethnography of Long-Term Holistic Tracking to Manage PCOS
Kang, D., Li, J., Leshed, G., Rzeszotarski, J. M., & Lu, X. (2025) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3706598.3713619 · Cited by 23
“…hyperandrogenism (high levels of male hormones) and insulin resistance (cells that do not respond well to insulin) are highly associated with PCOS [32, 94, 119, 138], and hyperandrogenism and insulin resistance reinforce each other [94], the root causes of PCOS are not yet fully understood [55].”
CircRNA circ_0043533 facilitates cell growth in polycystic ovary syndrome by targeting miR-1179
Chen, A., Jin, R.-Y., Zhou, W., Ye, Y.-J., Lu, J., Ren, Y., & Xuan, F. (2022) · Reproductive Biology · doi:10.1016/j.repbio.2022.100637 · Cited by 19
Farooq, U., Mirza, M. A., Alshetaili, A., Mohapatra, S., Jain, P., Hassan, N., Iqbal, Z., & Ali, A. (2024) · Nanoscale Advances · doi:10.1039/d3na00943b · Cited by 19
Javidan, A., Azarboo, A., Jalali, S., Fallahtafti, P., Moayyed, S., Ghaemi, M., Tarafdari, A., & Hantoushzadeh, S. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01717-z · Cited by 20
“Furthermore, up to 75% of affected individuals exhibit impaired insulin action, underscoring the strong association between insulin resistance and PCOS [5–7].”
Dilimulati, D., Shao, X., Wang, L., Cai, M., Zhang, Y., Lu, J., Wang, Y., Liu, H., Kuang, M., Chen, H., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/55883 · Cited by 17
“Using gold standard procedures, it was estimated that approximately 75% of patients with PCOS had insulin resistance and that the endocrine and reproductive characteristics of PCOS can be brought on by insulin resistance [27].”
Mechanism and recent updates on insulin-related disorders
Kumar, S., Senapati, S., Bhattacharya, N., Bhattacharya, A., Maurya, S. K., Husain, H., Bhatti, J. S., & Pandey, A. K. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i25.5840 · Cited by 20
Ke, Y., Hu, J., Zhu, Y., Wang, Y., Chen, S., & Liu, S. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00841-1 · Cited by 16
“Polycystic ovary syndrome (PCOS), the most common endocrine disease in females during the reproductive period [20, 21], often presents with severe metabolic disorders [20] and is particularly linked to insulin resistance [22].”
BackgroundTuretta, C., Giannini, A., Tarsitano, M. G., Gianfrilli, D., Paoli, A., Kontopantelis, E., Angelis, E. D., Minnetti, M., Poggiogalle, E., Colizza, A., et al. (2025) · Gynecologic and Obstetric Investigation · doi:10.1159/000543941 · Cited by 17
“Therefore, while it is dif fi cult to establish the correct chain of events [48], it is evident that PCOS patients have increased metabolic risk due to hormonal imbalances.”
Acupuncture therapy protects PCOS patients with diabetes by regulating miR-32-3p/PLA2G4A pathway.
Wu, J., & Chen, X. (2021) · Europe PMC (PubMed Central) · Cited by 15
Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
Unfer, V., Russo, M., Aragona, C., Bilotta, G., Oliva, M. M., & Bizzarri, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061759 · Cited by 18
“Since a high percentage of women presenting PCOS also exhibit metabolic issues such as IR, hyperinsulinemia, obesity, and diabetes, it may be hypothesized that hyperandrogenic manifestations rely on alterations in the endocrine and metabolic pattern [34,35].”
BackgroundZhu, B., Ma, Z., Zhu, Y., Fang, L., Zhang, H., Kong, H., & Xia, D. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000483 · Cited by 16
Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
Ilias, Ι., Goulas, S., & Zabulienė, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i12.2711 · Cited by 16
Zhu, M., Wang, K., Feng, J., Liu, Y., Guan, M., Wang, Y., & Wu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1502321 · Cited by 14
“Though IR develops independently from PCOS, it was found to induce the endocrine and reproductive traits of PCOS (32); this result was similar to our fi ndings.”
Naeem, I., Zehra, A., Rehman, F., Hussain, A., Hussain, N., Hussain, N., WASEEM, M., Alqahtani, R. M., Shamlan, G. H., Ahmed, I. A. M., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01741-z · Cited by 22
“This study showed that SNPs are linked with BMI and are associated with an increased possibility of PCOS [76].”
Han, Y., Lin, B., Lu, W., Wang, X., Tang, W.-S., Tao, X., Cai, H., He, C., & Liu, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1057376 · Cited by 15
“The inextricable relationship between hyperandrogenemia and IR is getting more attention as the understanding of this disorder increases (38, 39).”
BackgroundChen, Y., Zhang, Q., Ma, J., & Yu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.963213 · Cited by 17
“The key words are divided into six categories:(1) the interaction between IR and chronic inflammation and adipocyte metabolic disorders;(2) the relationship between IR and metabolic syndrome and NAFLD;(3) the interaction between IR and hyperandrogenism;(4) the relationship between IR and abnormal lipid metabolism;(5)…”
BackgroundLiu, Z., & Wang, K. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05944-4 · Cited by 14
“In addition to these diagnostic features, obesity and insulin resistance (IR) are also common abnormalities associated with PCOS [40, 41].”
BackgroundSerum-Derived Exosomal microRNAs in Lipid Metabolism in Polycystic Ovary Syndrome
Hong, Y., Wu, J., Yu, S., Miao, H., & Lin, S. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00930-1 · Cited by 14
“Previous studies have indicated that the cause of PCOS is related to IR, and it is estimated that about 80% of PCOS women develop IR [13].”
BackgroundLejman-Larysz, K., Pietrzyk, D., Ćwiertnia, A., Kozłowski, M., Kwiatkowski, S., Szydłowska, I., Nawrocka-Rutkowska, J., Brodowski, J., Sowińska-Przepiera, E., Cymbaluk‐Płoska, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11071953 · Cited by 12
“Increased ovarian androgen production is caused by a modified steroidogenesis pathway and the influence of external factors such as hyperinsulinemia on the ovary [5].”
BackgroundWang, J., Huang, Z., Cao, Z., Luo, Y., Liu, Y., Cao, H., Tang, X., & Fang, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011146 · Cited by 12
“Insulin resistance also often occurs in PCOS; it is present in up to 75% of patients [3] and is closely related to female reproductive function [4].”
BackgroundScannell, N., Villani, A., Moran, L., & Mantzioris, E. (2025) · Proceedings of the Nutrition Society · doi:10.1017/s0029665124007584 · Cited by 12
Karam, M., Najjar, H., El-Sabban, M. E., Hamadé, A., & Najjar, F. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10505-5 · Cited by 11
“A bidirectional correlation between hyperandrogenism and insulin resistance prevails and poses multiple ambiguities as to whether insulin resistance could be considered a cause or a resulting symptom of PCOS [24].”
BackgroundKolnikaj, T. S., Herman, R., Janež, A., & Jensterle, M. (2022) · Life · doi:10.3390/life12111906 · Cited by 12
Ünlü, C., Güney, G., Ersak, D. T., Kösem, A., Tarlan, N., & Tokmak, A. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0455 · Cited by 13
Sparić, R., Andjić, M., Rakić, A., Bjekić-Macut, J., Livadas, S., Kontić‐Vučinić, O., Mastorakos, G. P., & Μacut, D. (2023) · HORMONES · doi:10.1007/s42000-023-00494-y · Cited by 12
“While insulin resistance is commonly observed in women with PCOS and there is a bidirectional link between hyper-androgenism and insulin resistance, the precise connection between insulin resistance and reproductive abnormalities in PCOS women remains unclear [15, 16].”
Zhang, J., Saeed, A., Hussain, M., Siddique, R., Xu, H., Bazmi, R. R., Hussain, L., & Lv, G. (2024) · Journal of Food Biochemistry · doi:10.1155/2024/1003797 · Cited by 13
Zhang, Z., Huo, P. F., Lei, X., Xue, H., Yang, X., Le, J., & Zhang, S. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104750 · Cited by 10
Panchpuri, M., Kisku, A., Painuli, R., Pant, G., & Kumar, C. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02117-5 · Cited by 13
“…stated that at least one of the two criteria (namely, insulin resistance and/or glucose intolerance and elevated BMI) is necessary for the diagnosis of metabolic abnormalities in PCOS, with overweight or obesity as essential criteria for referral for metabolic assessments (Moghetti and Tosi 2021).”
The role of macrophages in polycystic ovary syndrome: A review
Li, L., Xiao, Y., Wen, W., Liu, Q., Wei, L., Liu, P., & Li, M. (2025) · Medicine · doi:10.1097/md.0000000000042228 · Cited by 11
“[46] Those with PCOS who are overweight are more likely to require regular monitoring and analysis of their blood glucose levels.”
Nandi, A., Singh, K. D., & Sharma, K. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07187-w · Cited by 13
Qi, S., Yu, H., Hu, W., Xia, D., Shi, Q., & Wang, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-15026-4 · Cited by 13
Singh, J. R., Jain, A., Wadhwa, N., Tilak, H. R., & Ahirwar, A. K. (2022) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2022-0050 · Cited by 9
“De este modo, las mujeres con SOP presentan un mayor grado de resistencia a la insulina (RI) [1, 3], definida como un estado en el que se requiere una cantidad de insulina superior a la normal para inducir una respuesta [4].”
BackgroundAre menstrual disorders in adolescent girls related to metabolic disorders?
Foryś-Dworniczak, E., Baran, A., Dziurdzia, A., Jarosz-Wójcik, E., Matusik, P., Gawlik, A., Tomaszewski, R., & Zachurzok, A. (2023) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2023.125364 · Cited by 10
“IR and hyperinsulinaemia are considered important components in the pathogenesis of this endocrinopathy [29].”
BackgroundMoghetti, P., Catellani, C., Sartori, C., Migazzi, M., Cirillo, F., Villani, M., Buia, V., Righi, B., Dauriz, M., Fiers, T., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02119-y · Cited by 9
“It has been hypothesized that hyperinsulinemia, induced by the IR status, contributes to hyperandro-genism, since insulin may enhance both ovarian and adrenal steroidogenesis [5].”
BackgroundSelf-citationScannell, N., Mantzioris, E., Rao, V. S., Pandey, C., Ee, C., Mousa, A., Moran, L., & Villani, A. M. (2023) · Biomedicines · doi:10.3390/biomedicines11123349 · Cited by 12
Elevated IGFBP7 expression in follicular granulosa cells promotes PCOS pathogenesis
Chen, L., Hui, L., Wang, Y., Yao, X., & Li, J. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167743 · Cited by 9
Shen, W., Jin, B., Han, Y., Wang, H., Jiang, H., Zhu, L., Han, M., Zhang, J., & Zhang, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9971403 · Cited by 9
“0e recent studies have shown that S. miltiorrhiza extract can reverse reproductive disorders by regulating the expression of androgen receptor, CYP11, CYP17, and CYP19, thus improving reproductive hormone production such as T, LH, and FSH [15, 21].”
BackgroundInfluentialGeneral infertility workup in times of high assisted reproductive technology efficacy
Polyzos, N. P., Ayoubi, J. M., & Pirtea, P. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.05.019 · Cited by 9
Naz, M. S. G., Jahanfar, S., & Tehrani, F. R. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.11.007 · Cited by 9
Tajada, M., Dieste-Pérez, P., Sanz-Arenal, A., Pérez‐Roncero, G. R., López-Baena, M. T., & Pérez-López, F. R. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2047922 · Cited by 10
“to identify normoandrogenic and hyperandrogenic cases [58].”
Lin, Y., Liu, X., Li, X., Tang, Q., Meng, F., & Chen, W. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220508180611 · Cited by 10
Wu, H., Yang, M., Yan, C., Liu, M., Wang, H., & Zhang, W. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13230 · Cited by 10
“Approximately 75% of PCOS cases are associated with IR (4).”
BackgroundÖzdemir, M., Mümüşoğlu, S., & Bilgiç, P. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01808-8 · Cited by 10
“Excess androgens, especially in muscle and fat tissue, can impair insulin action [45].”
Bagheri, R. B., Chavoshinezhad, N., Barghi, B., Soleymaniinallou, M., Shokoohi, M., Najafnezhad, P., Khaki, A. A., & Oskouei, F. D. (2024) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2024.6004 · Cited by 8
“The PCOS group exhibited a significant increase in serum insulin levels, underscoring insulin resistance, a common feature of PCOS (20).”
Yi, W., Zhang, M., Yuan, X., Shi, L., Yuan, X., Sun, M., Liu, J., Cai, H., & Lv, Z. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.05.007 · Cited by 9
Screening target genes for the treatment of PCOS via analysis of single-cell sequencing data
Lu, Z., Chen, C., Gao, Y., Li, Y., Zhao, X., Zhang, H., Wei, Q., Zeng, X., Li, Y., & Wan, M. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2136401 · Cited by 8
Hosseinkhani, F., Hosseinifar, S., & Tabandeh, M. R. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106546 · Cited by 7
Tosi, F., Lando, M. G., Rosmini, F., Lucarini, F., Fiorio, V., Zanolin, M. E., Fiers, T., Kaufman, J., & Moghetti, P. (2025) · Human Reproduction · doi:10.1093/humrep/deaf114 · Cited by 7
Self-citationPolycystic ovary syndrome and organochlorine pesticides: exploring potential links and mechanisms
Yin, S., Yang, W., Lin, F., Jia, M., Feng, Y., Chen, Y., Bai, X., Dong, Y., Mao, S., Hayat, K., et al. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1563414 · Cited by 7
“IR is one of the major symptoms of PCOS, as approximately 75% of patients with PCOS will develop it (99), and a higher percentage of patients with PCOS who are obese will suffer from IR (100).”
Physiological and pathophysiological roles of inositols
Monastra, G., Dinicola, S., & Unfer, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91673-8.00008-x · Cited by 7
Wang, D., Nan, N., Bing, H., & He, B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1241734 · Cited by 7
“IR occurs in approximately 75% of PCOS patients, with a higher proportion of IR in PCOS patients with obesity, and IR interacts with PCOS to worsen this situation (30, 31).”
BackgroundStereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition
Tortolini, C., Gigli, V., Rizzo, F., Lenzi, A., Bizzarri, M., Angeloni, A., & Antiochia, R. (2023) · Sensors · doi:10.3390/s23229211 · Cited by 7
Hu, Z., Zeng, R., Tang, Y., Liao, Y., Li, T., & Qin, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1413068 · Cited by 8
Jiao, X., Zhang, Q., Ye, G., Fang, X., Xie, D., & Wang, L. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf071 · Cited by 7
Metadata
- Authors
- Moghetti, P., & Tosi, F.
- Affiliations
- University of Verona (IT)
- Corresponding author
- Moghetti, P.
- ORCID
- Venue
- Journal of Endocrinological Investigation
- Published
- 2020-07-09
- Volume
- 44
- Issue
- 2
- Pages
- 233-244
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W3041550542
- Cited by
- 209
- References
- 92
- Citations by year
- 2026: 30 · 2025: 32 · 2024: 36 · 2023: 48 · 2022: 47 · 2021: 15 · 2020: 1
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università degli Studi di Verona
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, insulin resistance, hyperinsulinemia, hyperandrogenism, excess body fat, fetal programming, metabolic abnormalities, reproductive endocrine disorders, pathogenesis
- MeSH terms
- Animals, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.